Sebastian Theurich
Papers
1
Total Citations
45
H-Index
1
About
Dr. Sebastian Theurich is a leading clinician-scientist whose research bridges the frontiers of radiation oncology and cancer immunotherapy, with a particular focus on melanoma and brain metastases. His most cited work, a landmark 2018 study, was among the first to rigorously examine the safety and efficacy of combining robotic stereotactic radiosurgery with anti-PD-1 immune checkpoint inhibitors in melanoma patients with brain metastases. This work, which has garnered 45 citations, provided critical early evidence that the combination is not only feasible but can achieve excellent local control without prohibitive acute toxicity, helping to shape modern clinical practice for this challenging patient population. Dr. Theurich’s contributions extend beyond this pivotal study; he is recognized for advancing our understanding of the interplay between radiotherapy and the immune system, exploring how these modalities can be synergistically harnessed to improve outcomes. His research continues to drive the evolution of combination treatment paradigms, offering new hope for patients with advanced melanoma and solidifying his reputation as a key innovator at the intersection of radiation and immunotherapy.
Research Focus
Key Achievements
Top Papers
- 1